Aside from maybe high school biology classes, the first time many people heard of mRNA was during the pandemic because of the vital role MRNA technology played in COVID-19 vaccines.
Over the last several days, the safety and efficacy of messenger RNA, or mRNA, vaccines have come under intense scrutiny. On Tuesday, the U.S. Food and Drug Administration announced plans to limit ...
Researchers are edging closer to something long imagined but never quite within reach: a single vaccine platform that could ...
StockStory.org on MSN

Why Moderna (MRNA) stock is up today

What Happened? Shares of biotechnology company Moderna (NASDAQ:MRNA) jumped 4% in the morning session after the company ...
mRNA innovation is one of the most exciting and impactful areas of healthcare globally today. A process that has increasingly expansive application potential in treating diseases or functioning as a ...
SMRTS, a smart mRNA system, enables cell‑selective gene expression, expanding the mRNA toolbox for precision cancer therapies.
mRNA expert Jeff Coller spoke with Live Science about the future of mRNA vaccines in the United States in the aftermath of huge federal funding cuts. When you purchase through links on our site, we ...
mRNA vaccines train the immune system in a similar way to traditional vaccines, but they use a different strategy to get there. When you purchase through links on our site, we may earn an affiliate ...
SAN ANTONIO – The federal government’s decision to slash $500 million in funding for mRNA vaccine research has sparked concern among health experts. “The news that we’re going to block a Nobel ...
Mount Sinai researchers developed a first-in-class cell-selective modRNA translation system that turns therapeutic genes on ...
On Sept. 4, 2025, Health and Human Services Secretary Robert F. Kennedy Jr. is scheduled to testify before the Senate Finance Committee, where he is expected to face questions about his vaccine ...
On first glance, the data that Health and Human Services Secretary Robert F. Kennedy Jr. cited to justify canceling some $500 million in federal grants for mRNA vaccine research looked impressive. The ...